Pharma Dynamics

What Pharma Dynamics does

Pharma Dynamics is a South African generic pharmaceutical company headquartered in Cape Town with a regional office in Johannesburg, founded in the early 2000s and operating as a wholly owned subsidiary of the Indian global pharmaceutical group Lupin Limited. The company distributes a portfolio of 104 commercial pharmaceutical brands — including 25 market-leading products — through pharmacy networks and healthcare facilities across South Africa and seven additional African countries (Namibia, Botswana, Zambia, Zimbabwe, Mozambique, Angola, and Kenya). Pharma Dynamics has held the position of #1 cardiovascular (CVS) pharmaceutical supplier in South Africa by value and volume since 2011, with additional therapeutic coverage spanning women's health, mental health, diabetes, pain, antibiotics, urinary incontinence, allergies, men's health, and digestive health.

The company's product infrastructure combines conventional generic pharmaceutical distribution with a digital patient support layer called MyDynamics, a QR-code-accessed content platform offering condition-specific educational resources, lifestyle tips, mental health content, and heart-healthy recipes. In April 2026, Pharma Dynamics expanded its women's health offering by launching AVIBELA (a levonorgestrel 52 mg IUD) in South Africa through a partnership with US-based Medicines360, marking the country's first generic hormonal IUD. The company's go-to-market is sales-led, with field sales teams supporting B2B relationships with pharmacies and healthcare providers, complemented by direct supply relationships for specialty products such as the AVIBELA IUD.

Revenue is generated primarily through one-time sales of generic pharmaceutical products via established pharmacy and healthcare facility channels, with no public pricing disclosure and pharmaceutical pricing governed by South African regulatory frameworks. The customer base is heavily fragmented at the consumer level — patients purchasing through retail pharmacies — with the broader South African public healthcare system serving as an institutional channel. In December 2025, Pharma Dynamics divested its hospital operations to New Zealand-based AFT Pharmaceuticals, retaining the retail-generics and chronic-disease core while refocusing capital allocation toward women's health and primary-care expansion.

Name

Pharma Dynamics

Legal name

Pharma Dynamics Pty Ltd

Website

https://pharmadynamics.co.za

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharma Dynamics is a South African generic pharmaceutical company and wholly owned subsidiary of Lupin Limited, distributing 104 commercial brands (25 market-leading) across cardiovascular, women's health, mental health, and other therapeutic areas in 8 African countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

Keywords

• Generic pharmaceuticals
• Cardiovascular medications
• Women's health products
• Pharmaceutical distribution
• Long-acting contraceptives

Headquarters

HQ city

Cape Town

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Generic Pharmaceutical Sales: Revenue generated through the sale of generic medications across multiple therapeutic areas including cardiovascular, women's health, mental health, pain, antibiotics, diabetes, and urinary incontinence. Products are distributed through pharmacies and healthcare facilities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Pharma Dynamics is one of South Africa's leading generic pharmaceutical providers, selling a portfolio of 104 commercial brands across cardiovascular, women's health, mental health, pain, antibiotics, diabetes, urinary incontinence, allergies, men's health, digestive health, and bone and joint health therapeutic areas. It has held the #1 CVS pharmaceutical supplier position in South Africa by value and volume since 2011 and distributes products across 8 African countries. The company extends its offering with the MyDynamics digital patient support platform and the recently launched Avibela® levonorgestrel IUD.

Product overview

Pharma Dynamics is one of South Africa's leading generic medication providers offering a diversified portfolio of 104 commercial pharmaceutical brands, with 25 market-leading brands. The core product portfolio spans cardiovascular medications (where it holds the #1 market position in South Africa since 2011), alongside treatments for mental health, women's health, pain, antibiotics, diabetes, urinary incontinence, allergies, men's health, digestive health, and bone and joint health. The company extends its offering through MyDynamics, a patient support platform accessible via QR codes on product packaging that provides condition-specific educational content and lifestyle support. The recent addition of Avibela® (levonorgestrel 52 mg IUD) expands the women's health portfolio with a long-acting reversible contraception product.

Differentiator

Problem solved

Functional benefit

Brands

• MyDynamics: Online patient support platform providing educational resources, condition support, lifestyle tips, mental health insights, and heart-healthy recipes. Accessible via QR code on product packaging.

Products and services

• Avibela® A levonorgestrel 52mg hormonal intrauterine device (IUD) providing long-acting reversible contraception and treatment of heavy menstrual bleeding, with greater than 99% effectiveness for up to 6 years. Marketed to South African women and healthcare providers through hospital and pharmacy channels in partnership with Medicines360.
• Generic Medication Portfolio A portfolio of 104 commercial generic pharmaceutical brands spanning cardiovascular, women's health, mental health, pain, antibiotics, diabetes, urinary incontinence/overactive bladder, allergies, men's health, digestive health, and bone and joint health. Includes 25 market-leading brands and the #1 cardiovascular pharmaceutical range in South Africa by value and volume since 2011. Distributed to pharmacies, hospitals, and healthcare facilities across South Africa and 7 other African countries.

Quantifiable outcome

• More than 99% effective contraception for up to 6 years
• +1 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Medicines360coreStrategic or Co-development Partner · 22 April 2026Partnership between Medicines360 and Pharma Dynamics for the launch of Avibela levonorgestrel 52mg IUD in South Africa. Medicines360 contributes product development and quality assurance expertise while Pharma Dynamics provides local distribution capabilities. This partnership aims to expand women's health options in South Africa, addressing barriers including upfront cost and limited availability that have kept IUD uptake at only 1.9% of the national contraceptive method mix.
• Lupin LimitedcoreOthersPharma Dynamics is a wholly owned subsidiary of Lupin Limited, a global pharmaceutical company. This ownership provides strategic alignment, access to global product development resources, and manufacturing scale advantages.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Lupin Limited: Pharma Dynamics' parent company and one of India's largest generic pharmaceutical manufacturers. Comparable on therapeutic-area coverage (cardiovascular, central nervous system, diabetes), API/formulation capability, and emerging-market commercial model, though materially larger and globally diversified.
• Pfizer: Global pharmaceutical leader with an established South African commercial operation. Competes with Pharma Dynamics on cardiovascular, anti-infectives, women's health and pain, but from a global branded-innovator base rather than a generics-focused distribution model.
• Sanofi: Global pharmaceutical major with a meaningful South African and Sub-Saharan Africa footprint across branded prescription, vaccines and consumer health. Overlaps with Pharma Dynamics on cardiovascular, diabetes and central nervous system therapies, but competes from a global branded-innovator base rather than a generics-led model.
• Bayer: Global life sciences company with a substantial South African pharmaceutical and consumer health presence. Comparable on cardiovascular (especially antihypertensives) and women's health categories, though Bayer's portfolio spans branded prescription, consumer health, crop science and animal health.

Direct peers

• Adcock Ingram: Major South African pharmaceutical manufacturer with a portfolio of branded and generic prescription, OTC, and consumer health products. Direct competitor in cardiovascular, pain, women's health and central nervous system categories across the same pharmacy distribution channels.
• Cipla: Indian global generic pharmaceutical company with a significant South African and African presence through Cipla Medpro. Competes directly with Pharma Dynamics on generic respiratory, cardiovascular, antiretroviral and central nervous system therapies in the same pharmacy channels.
• Aspen Pharmacare: Africa's largest pharmaceutical manufacturer and distributor, headquartered in South Africa. Aspen competes directly with Pharma Dynamics across generics, OTC and branded pharmaceuticals across South Africa and broader African markets, with overlapping cardiovascular, women's health and central nervous system portfolios.
• AFT Pharmaceuticals: New Zealand-based specialty pharmaceutical company that acquired Pharma Dynamics' hospital operations in December 2025. Now a direct competitor in South African hospital-channel pharmaceuticals across several African territories, with overlapping specialty and prescription product lines.
• Glenmark Pharmaceuticals: India-headquartered global generic and specialty pharmaceutical company with presence in emerging markets including Africa. Comparable on generic portfolio breadth across dermatology, respiratory, cardiovascular and central nervous system, with similar emerging-market commercial model.

Others

• Medicines360: US-based nonprofit pharmaceutical company that partnered with Pharma Dynamics to launch Avibela (levonorgestrel 52mg IUD) in South Africa. Adjacent rather than competitive — Medicines360 contributes product development and quality assurance capabilities that complement Pharma Dynamics' African commercial and distribution platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/PharmaDynamicsSA
• LinkedInlinkedin.com/company/pharma-dynamics-pty-ltd
• Xx.com/pharmadynamics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Dynamics